Biomedrex Genetics
Main focus: Next-generation CRISPR-based antiviral therapies
Company stage: Pre-clinical
Diseases (gene editing): HIV-1, influenza, SARS-CoV-2
Genome editing tool: CRISPR
Funding stage: Private
Location: Huddinge, Sweden
Website: https://www.biomedrex.com/index.html
Biomedrex Genetics is a start-up company that develops novel antiviral treatments based on the CRISPR-Cas system. The company aims to treat various infectious diseases, with HIV-1 being the lead viral target. The company is currently conducting pre-clinical testing.